Exploratory Pathology in Action: Advancing Nonclinical Drug Development Across Therapeutic Areas, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn about the importance and value of incorporating exploratory pathology into nonclinical drug development programs. Attendees will gain insights into how exploratory pathology contributes to early development, lead optimization and mechanistic studies. The featured speakers will discuss how exploratory pathology can be utilized across therapeutic areas and integrate with specialty pathology evaluations.

TORONTO, Jan. 28, 2025 /PRNewswire-PRWeb/ -- Exploratory pathology leverages the knowledge and expertise of comparative medicine, pathological processes and biomedical research activities to understand mechanisms of disease and disease pathogenesis and help guide the evaluation and potential impact of treatments on health and disease progression.

This webinar will provide a comprehensive overview of how exploratory pathology can provide scientific expertise across multiple phases of drug development. Examples of how exploratory pathology contributes to early discovery, lead optimization and exploration of pathogenic mechanisms and how to address challenges across multiple therapeutic modalities will be discussed.

Attendees will also learn the importance and value of incorporating exploratory pathology components in their nonclinical drug development programs across multiple therapeutic areas, including neuropathology, immunopathology, ocular pathology and medical devices.

Register for this webinar today to learn how exploratory pathology can provide key pathologic data for nonclinical drug development programs across discovery and safety assessment.

Join experts from StageBio, Tracey L. Papenfuss, DVM, PhD, MS, DACVP, Senior Pathologist; and Stephanie M. Shrader, DVM, PhD, DACVP, Vice President of Pathology Solutions, for the live webinar on Thursday, February 13, 2025, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit Exploratory Pathology in Action: Advancing Nonclinical Drug Development Across Therapeutic Areas.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com

For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com

View original content to download multimedia:https://www.prweb.com/releases/exploratory-pathology-in-action-advancing-nonclinical-drug-development-across-therapeutic-areas-upcoming-webinar-hosted-by-xtalks-302361746.html

SOURCE Xtalks